company background image
EXAI

Exscientia NasdaqGS:EXAI Stock Report

Last Price

US$4.96

Market Cap

US$614.4m

7D

-14.0%

1Y

-79.4%

Updated

08 Dec, 2022

Data

Company Financials +
EXAI fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance0/6
Financial Health5/6
Dividends0/6

EXAI Stock Overview

Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs.

Exscientia plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Exscientia
Historical stock prices
Current Share PriceUS$4.96
52 Week HighUS$24.99
52 Week LowUS$4.90
Beta0
1 Month Change-28.32%
3 Month Change-45.01%
1 Year Change-79.45%
3 Year Changen/a
5 Year Changen/a
Change since IPO-81.70%

Recent News & Updates

Recent updates

The Exscientia plc (NASDAQ:EXAI) Analysts Have Been Trimming Their Sales Forecasts

Aug 31
The Exscientia plc (NASDAQ:EXAI) Analysts Have Been Trimming Their Sales Forecasts

Companies Like Exscientia (NASDAQ:EXAI) Can Afford To Invest In Growth

May 29
Companies Like Exscientia (NASDAQ:EXAI) Can Afford To Invest In Growth

Bullish: Analysts Just Made A Sizeable Upgrade To Their Exscientia plc (NASDAQ:EXAI) Forecasts

Jan 09
Bullish: Analysts Just Made A Sizeable Upgrade To Their Exscientia plc (NASDAQ:EXAI) Forecasts

Shareholder Returns

EXAIUS BiotechsUS Market
7D-14.0%-0.3%-3.7%
1Y-79.4%-11.2%-21.2%

Return vs Industry: EXAI underperformed the US Biotechs industry which returned -11.2% over the past year.

Return vs Market: EXAI underperformed the US Market which returned -21.2% over the past year.

Price Volatility

Is EXAI's price volatile compared to industry and market?
EXAI volatility
EXAI Average Weekly Movement11.5%
Biotechs Industry Average Movement11.1%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: EXAI is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: EXAI's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2012285Andrew Hopkinshttps://www.exscientia.ai

Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates.

Exscientia plc Fundamentals Summary

How do Exscientia's earnings and revenue compare to its market cap?
EXAI fundamental statistics
Market CapUS$614.39m
Earnings (TTM)-US$121.89m
Revenue (TTM)US$30.01m

20.3x

P/S Ratio

-5.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EXAI income statement (TTM)
RevenueUK£24.55m
Cost of RevenueUK£28.59m
Gross Profit-UK£4.03m
Other ExpensesUK£95.69m
Earnings-UK£99.73m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.81
Gross Margin-16.44%
Net Profit Margin-406.22%
Debt/Equity Ratio0.06%

How did EXAI perform over the long term?

See historical performance and comparison